HomeComparePGXPF vs JNJ

PGXPF vs JNJ: Dividend Comparison 2026

PGXPF yields 1543.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PGXPF wins by $909208637.41M in total portfolio value
10 years
PGXPF
PGXPF
● Live price
1543.21%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$909208637.43M
Annual income
$806,413,919,698,128.00
Full PGXPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PGXPF vs JNJ

📍 PGXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPGXPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PGXPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PGXPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PGXPF
Annual income on $10K today (after 15% tax)
$131,172.84/yr
After 10yr DRIP, annual income (after tax)
$685,451,831,743,408.80/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PGXPF beats the other by $685,451,831,742,705.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PGXPF + JNJ for your $10,000?

PGXPF: 50%JNJ: 50%
100% JNJ50/50100% PGXPF
Portfolio after 10yr
$454604318.73M
Annual income
$403,206,959,849,477.90/yr
Blended yield
88.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PGXPF
No analyst data
Altman Z
-49.0
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PGXPF buys
0
JNJ buys
0
No recent congressional trades found for PGXPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPGXPFJNJ
Forward yield1543.21%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$909208637.43M$20.0K
Annual income after 10y$806,413,919,698,128.00$827.78
Total dividends collected$901746059.45M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PGXPF vs JNJ ($10,000, DRIP)

YearPGXPF PortfolioPGXPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$165,021$154,320.99$10,676$355.77+$154.3KPGXPF
2$2,556,591$2,380,018.86$11,407$389.39+$2.55MPGXPF
3$37,195,828$34,460,275.74$12,198$426.53+$37.18MPGXPF
4$508,362,435$468,562,898.06$13,056$467.62+$508.35MPGXPF
5$6,528,936,497$5,984,988,692.44$13,987$513.12+$6528.92MPGXPF
6$78,823,022,073$71,837,060,020.77$14,998$563.56+$78823.01MPGXPF
7$894,882,420,902$810,541,787,284.32$16,098$619.52+$894882.40MPGXPF
8$9,557,644,508,792$8,600,120,318,426.10$17,295$681.69+$9557644.49MPGXPF
9$96,069,829,660,098$85,843,150,035,690.97$18,599$750.82+$96069829.64MPGXPF
10$909,208,637,434,433$806,413,919,698,128.00$20,022$827.78+$909208637.41MPGXPF

PGXPF vs JNJ: Complete Analysis 2026

PGXPFStock

Pelangio Exploration Inc., a mineral exploration company, engages in the acquisition, exploration, and development of mineral properties. It holds interests in various gold properties in Canada, Africa, and Ghana. The company was incorporated in 2008 and is headquartered in Toronto, Canada.

Full PGXPF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PGXPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PGXPF vs SCHDPGXPF vs JEPIPGXPF vs OPGXPF vs KOPGXPF vs MAINPGXPF vs ABBVPGXPF vs MRKPGXPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.